PIM1
Top View
- The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
- Lestaurtinib
- Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase with Potent Antimelanoma Activity
- Discovery of Potent and Selective MRCK Inhibitors with Therapeutic
- The Kinetics of G2 and M Transitions Regulated by B Cyclins
- The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
- Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
- PAI1 Is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208
- Phosphorylation of DEPDC5, a Component of the GATOR1 Complex, Releases Inhibition of Mtorc1 and Promotes Tumor Growth
- Pim1 Kinase Is Required to Maintain Tumorigenicity in MYC-Expressing Prostate Cancer Cells
- Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity Johannes C
- Identification of Gefitinib Off-Targets Using a Structure-Based Systems
- Cancer Susceptibility Mutations in Patients with Urothelial Malignancies the Following Represents Disclosure Information Provided by Authors of This Manuscript
- Structural Analysis of PIM1 Kinase Complexes with ATP-Competitive Inhibitors Received: 7 July 2017 Jozefna Bogusz1,2, Karol Zrubek1,2, Krzysztof P
- Supporting Information for “A High-Throughput Targeted Proteomic Approach for Comprehensive
- Precision Medicine for Diffuse Large B-Cell Lymphoma Megan S
- Pim Kinases Promote Cell Cycle Progression by Phosphorylating
- Targeting CDK9 for Anti-Cancer Therapeutics